ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Physical Medicine Rehabilitation

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,474Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 52

$686K Total Retail Price of All Prescriptions

Rank: 3 out of 52

564 Patients Receiving at Least One Drug in Part D
33%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

51% of this provider’s 564 patients filled at least one prescription for a schedule two drug, compared to an average of 24%.

Schedule Three
Controlled Substances

60% of this provider’s 564 patients filled at least one prescription for a schedule three drug, compared to an average of 37%.

Risky Drugs to Seniors

12% of this provider’s 2,769 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 3%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 15%.

Prescription Price

$72 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
HYDROCODONE-ACETAMINOPHEN 1,965 736 S3 1 1
TIZANIDINE HCL 583 128 2 6
OXYCODONE HCL-ACETAMINOPHEN 581 155 S2 3 3
FENTANYL 464 107 S2 4 10
CARISOPRODOL 402 97 R 5 7
GABAPENTIN 349 111 6 2
METHOCARBAMOL 338 109 R 7 17
LYRICA 335 45 8 13
MORPHINE SULFATE ER 315 64 S2 9 4
BACLOFEN 310 86 10 12
ENDOCET 264 64 S2 11 13
TOPIRAMATE 257 66 12 30
CYMBALTA 236 71 13 16
MELOXICAM 234 109 14 9
OXYCODONE HCL 230 54 S2 15 5
OXYCONTIN 228 75 S2 16 20
TRAMADOL HCL 213 85 17 8
CYCLOBENZAPRINE HCL 210 46 R 18 11
OPANA ER 165 28 S2 19 24
AMITRIPTYLINE HCL 135 50 R 20 22
SULINDAC 134 27 21 53
ZOLPIDEM TARTRATE 129 36 22 15
TRAZODONE HCL 126 29 23 21
LIDODERM 107 49 24 29
BUSPIRONE HCL 82 17 25 63
CLONAZEPAM 77 36 26 49
DICLOFENAC SODIUM 76 45 27 27
CELEBREX 76 37 27 50
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 1, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.